ABT vs WENNU
Abbott Laboratories (ABT) versus Wen Acquisition Corp. (WENNU) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Wen Acquisition Corp. (WENNU) is a shell companies company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
WENNU does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. WENNU currently screens at market cap $0.
Not investment advice. Open the ABT and WENNU stock pages for the full models.
Not investment advice.